SHARON CARRIGAN: Open Payments
NPI 1831852151 · THE VILLAGES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,323 in 124 payments from 16 companies in 2025. Trend: 2023 $1,451 · 2024 $2,200 · 2025 $2,323
Food & beverage: $2,289Education: $35
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $393 |
| GlaxoSmithKline, LLC. | 17 | $365 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $246 |
| Verona Pharma, Inc. | 14 | $207 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $191 |
| Regeneron Healthcare Solutions, Inc. | 9 | $191 |
| Insmed, Inc. | 8 | $156 |
| Grifols USA, LLC | 4 | $112 |
| Viatris Specialty LLC | 6 | $96 |
| Pulmonx Corporation | 4 | $86 |
Products named: DUPIXENT, GLASSIA, BREZTRI, TRELEGY ELLIPTA, Ohtuvayre, OFEV, NUCALA, Arikayce.
Industry payments across FL — which companies pay providers there.
